首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States
【24h】

Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States

机译:在美国的活体供体肾移植受者中更好地从后代供体肾脏的贪污结果

获取原文
获取原文并翻译 | 示例
           

摘要

A recent study reported that kidney transplant recipients of offspring living donors had higher graft loss and mortality. This seemed counterintuitive, given the excellent HLA matching and younger age of offspring donors; we were concerned about residual confounding and other study design issues. We used Scientific Registry of Transplant Recipients data 2001‐2016 to evaluate death‐censored graft failure ( DCGF ) and mortality for recipients of offspring versus nonoffspring living donor kidneys, using Cox regression models with interaction terms. Recipients of offspring kidneys had lower DCGF than recipients of nonoffspring kidneys (15‐year cumulative incidence 21.2% vs 26.1%, P ??.001). This association remained after adjustment for recipient and transplant factors (adjusted hazard ratio [ aHR ] =? 0.73 0.77 0.82 , P ??.001), and was attenuated among African American donors ( aHR 0.77 0.85 0.95 ; interaction: P ?=?.01) and female recipients ( aHR 0.77 0.84 0.91 , P ??.001). Although offspring kidney recipients had higher mortality (15‐year mortality 56.4% vs 37.2%, P ??.001), this largely disappeared with adjustment for recipient age alone ( aHR ?=? 1.02 1.06 1.10 , P ?=?.002) and was nonsignificant after further adjustment for other recipient characteristics ( aHR ?=? 0.93 0.97 1.01 , P ?=?.1). Kidneys from offspring donors provided lower graft failure and comparable mortality. An otherwise eligible donor should not be dismissed because they are the offspring of the recipient, and we encourage continued individualized counseling for potential donors.
机译:最近的一项研究报告称,后代活体供体的肾移植受者具有更高的接枝损失和死亡率。鉴于出色的HLA匹配和年龄的后代捐赠者,这似乎是违反直觉的;我们担心剩余混杂和其他研究设计问题。我们使用了移植受者数据2001-2016的科学登记,以评估死亡丧失的移植物失败(DCGF)和用于后代与非OFFSPRING LIFINOR肾脏的接受者的死亡率,使用COX回归模型与交互术语。后代肾脏的接受者的DCGF低于非OFFSPRING肾脏的受体(15年累积发生率为21.2%vs26.1%,p≤001)。该关联仍然在调整受体和移植因子(调整后的危险比[AHR] = 0.73 0.77 0.82,p≤001),并在非洲裔美国捐赠者中衰减(AHR 0.77 0.85 0.95;相互作用:P?= ?.01)和女性接受者(AHR 0.77 0.84 0.91,p≤001)。虽然后代肾脏受体具有较高的死亡率(15年死亡率56.4%Vs 37.2%,p?001),但这在很大程度上消失了对受体年龄的调整(AHR?=?1.02 1.06 1.10,P?= ?. 002)在进一步调整其他受体特征(AHRα= 0.93 0.97 1.01,P?= 1)后,002)并不显着。来自后代捐赠者的肾脏提供了较低的移植衰竭和可比性的死亡率。不应驳回否则符合条件的捐助者,因为他们是收件人的后代,我们鼓励继续持续个性化的潜在捐助者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号